BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32145665)

  • 1. Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism.
    Foss JD; Nayak SU; Tallarida CS; Farkas DJ; Ward SJ; Rawls SM
    Drug Alcohol Depend; 2020 Apr; 209():107946. PubMed ID: 32145665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive Effects of
    Obeng S; Leon F; Patel A; Zuarth Gonzalez JD; Chaves Da Silva L; Restrepo LF; Gamez-Jimenez LR; Ho NP; Guerrero Calvache MP; Pallares VLC; Helmes JA; Shiomitsu SK; Soto PL; McCurdy CR; McMahon LR; Wilkerson JL; Hiranita T
    J Pharmacol Exp Ther; 2022 Dec; 383(3):182-198. PubMed ID: 36153006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kratom alkaloid mitragynine: Inhibition of chemotherapy-induced peripheral neuropathy in mice is dependent on sex and active adrenergic and opioid receptors.
    Farkas DJ; Foss JD; Ward SJ; Rawls SM
    IBRO Neurosci Rep; 2022 Dec; 13():198-206. PubMed ID: 36093282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid mechanisms contribute to the therapeutic efficacy of the kratom alkaloid mitragynine against neuropathic, but not inflammatory pain.
    Farkas DJ; Inan S; Heydari LN; Johnson CT; Zhao P; Bradshaw HB; Ward SJ; Rawls SM
    Life Sci; 2023 Sep; 328():121878. PubMed ID: 37392779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diluted bee venom injection reduces ipsilateral mechanical allodynia in oxaliplatin-induced neuropathic mice.
    Yoon SY; Yeo JH; Han SD; Bong DJ; Oh B; Roh DH
    Biol Pharm Bull; 2013; 36(11):1787-93. PubMed ID: 23985901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats.
    Hiranita T; Leon F; Felix JS; Restrepo LF; Reeves ME; Pennington AE; Obeng S; Avery BA; McCurdy CR; McMahon LR; Wilkerson JL
    Psychopharmacology (Berl); 2019 Sep; 236(9):2725-2734. PubMed ID: 31098655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kratom pharmacology: Clues from planarians exposed to mitragynine.
    Uddin S; Wiah S; Kim T; Watson MN; Jennings T; Rawls SM
    Physiol Behav; 2021 Oct; 239():113499. PubMed ID: 34146575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abuse liability and therapeutic potential of the Mitragyna speciosa (kratom) alkaloids mitragynine and 7-hydroxymitragynine.
    Hemby SE; McIntosh S; Leon F; Cutler SJ; McCurdy CR
    Addict Biol; 2019 Sep; 24(5):874-885. PubMed ID: 29949228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasonic vocalizations of preweanling rats: involvement of both alpha(2)-adrenoceptor and kappa-opioid receptor systems.
    Nazarian A; Krall CM; Osburn JR; McDougall SA
    Eur J Pharmacol; 2001 Mar; 415(2-3):165-71. PubMed ID: 11274995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential contribution of opioid and noradrenergic mechanisms of tapentadol in rat models of nociceptive and neuropathic pain.
    Schröder W; Vry JD; Tzschentke TM; Jahnel U; Christoph T
    Eur J Pain; 2010 Sep; 14(8):814-21. PubMed ID: 20541444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
    Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
    J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal.
    Aley KO; Levine JD
    J Neurosci; 1997 Jan; 17(2):735-44. PubMed ID: 8987795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opioid receptors mediate the acquisition, but not the expression of mitragynine-induced conditioned place preference in rats.
    Yusoff NHM; Mansor SM; Müller CP; Hassan Z
    Behav Brain Res; 2017 Aug; 332():1-6. PubMed ID: 28559179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal.
    Wilson LL; Chakraborty S; Eans SO; Cirino TJ; Stacy HM; Simons CA; Uprety R; Majumdar S; McLaughlin JP
    Cell Mol Neurobiol; 2021 Jul; 41(5):1131-1143. PubMed ID: 33433723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuation of pain behaviour by local administration of alpha-2 adrenoceptor antagonists to dorsal root ganglia in a rat radiculopathy model.
    Ogon I; Takebayashi T; Miyakawa T; Iwase T; Tanimoto K; Terashima Y; Jimbo S; Kobayashi T; Tohse N; Yamashita T
    Eur J Pain; 2016 May; 20(5):790-9. PubMed ID: 26492290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinociceptive action of isolated mitragynine from Mitragyna Speciosa through activation of opioid receptor system.
    Shamima AR; Fakurazi S; Hidayat MT; Hairuszah I; Moklas MAM; Arulselvan P
    Int J Mol Sci; 2012; 13(9):11427-11442. PubMed ID: 23109863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabidiol and mitragynine exhibit differential interactive effects in the attenuation of paclitaxel-induced mechanical allodynia, acute antinociception, and schedule-controlled responding in mice.
    Ortiz YT; Bilbrey JA; Felix JS; Kienegger EA; Mottinelli M; Mukhopadhyay S; McCurdy CR; McMahon LR; Wilkerson JL
    Pharmacol Rep; 2023 Aug; 75(4):937-950. PubMed ID: 37243887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacopuncture With Scolopendra subspinipes Suppresses Mechanical Allodynia in Oxaliplatin-Induced Neuropathic Mice and Potentiates Clonidine-induced Anti-allodynia Without Hypotension or Motor Impairment.
    Yoon SY; Lee JY; Roh DH; Oh SB
    J Pain; 2018 Oct; 19(10):1157-1168. PubMed ID: 29758357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative Pharmacokinetics of Mitragynine after Oral Administration of Mitragyna speciosa (Kratom) Leaf Extracts in Rats.
    Avery BA; Boddu SP; Sharma A; Furr EB; Leon F; Cutler SJ; McCurdy CR
    Planta Med; 2019 Mar; 85(4):340-346. PubMed ID: 30452072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and neurochemical characterization of kratom (Mitragyna speciosa) extract.
    Stolt AC; Schröder H; Neurath H; Grecksch G; Höllt V; Meyer MR; Maurer HH; Ziebolz N; Havemann-Reinecke U; Becker A
    Psychopharmacology (Berl); 2014 Jan; 231(1):13-25. PubMed ID: 23846544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.